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Abstract
Background: Six Nigerian medicinal plants Terminalia avicennioides, Phylantus discoideus, Bridella
ferruginea, Ageratum conyzoides, Ocimum gratissimum and Acalypha wilkesiana used by traditional
medical practitioners for the treatment of several ailments of microbial and non-microbial origins
were investigated for in vitro anti-methicillin Resistant Staphylococcus aureus (MRSA) activity.
Methods: Fresh plant materials were collected from the users. Water and ethanol extracts of the
shredded plants were obtained by standard methods. The Bacterial cultures used were strains of
MRSA isolated from patients. MRSA was determined by the reference broth microdilution
methods using the established National Committee for Clinical Laboratory Standards break points.
Staphylococcus aureus NCIB 8588 was used as a standard strain. Susceptibility testing and
phytochemical screening of the plant extracts were performed by standard procedures. Controls
were maintained for each test batch.
Results: Both water and ethanol extracts of T. avicennioides, P. discoideus, O. gratissimum, and A.
wilkesiana were effective on MRSA. The Minimum Inhibition Concentration (MIC) and Minimum
Bactericidal Concentration (MBC) of the ethanol extracts of these plants range from 18.2 to 24.0
mcg/ml and 30.4 to 37.0 mcg/ml respectively. In contrast, MIC range of 30.6 to 43.0 mcg/ml and
55.4 to 71.0 mcg/ml were recorded for ethanol and water extracts of B. ferruginea, and A. conyzoides
respectively. Higher MBC values were obtained for the two plants. These concentrations were too
high to be considered active in this study. All the four active plants contained at least trace amount
of anthraquinones.
Conclusion: Our results offer a scientific basis for the traditional use of water and ethanol
extracts of A. wilkesiana, O. gratissimum, T. avicennioides and P. discoideus against MRSA-associated
diseases. However, B. ferruginea and A. conyzoides were ineffective in vitro in this study; we therefore
suggest the immediate stoppage of their traditional use against MRSA-associated diseases in Lagos,
Nigeria.
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Over the last three decades, methicillin resistant Staphylo-
coccus aureus (MRSA) had caused major problems in hos-
pitals throughout the world[1]. The first outbreak caused
by MRSA occurred in European hospitals in the early
1960's[2]. During the late 1970's, strains of S. aureus
resistant to multiple antibiotics including methicillin and
gentamycin were increasingly responsible for many out-
breaks in the U.S.A and Great Britain[3], and by 1980's
MRSA was considered a major clinical and epidemiologi-
cal pathogen in human hospitals[4]. Since then strains of
MRSA and coagulase-negative Staphylococci had spread
worldwide. Recent reports indicated that MRSA strains
account for 10 to 40% of S. aureus isolated from some
European hospitals[5-7]
In many parts of the globe, particularly the developed
countries, fluoroquinolones (pefloxacin, ciprofloxacin
and ofloxacin) are recommended for serious infections
associated with Staphylococci, although, occasional resist-
ance among MRSA has been documented[2], Further-
more, in spite of recent reports of vancomycin resistant
strains MRSA in some parts of the globe, vancomycin still
remain the drug of choice for most MRSA-associated
diseases[9].
The use of medicinal plants all over the world predates the
introduction of antibiotics and other modern drugs into
Africa continent. Herbal medicine has been widely used
and formed an integral part of primary health care in
China[10], Ethiopia[11], Argentina[12] and Papau New
Guinea[13]. Traditional medical practitioners in South-
west, Nigeria, use a variety of herbal preparations to treat
different kinds of microbial diseases including MRSA-
associated diseases.
In recent times, the number of traditional healers claim-
ing the efficacies of six medicinal plants viz: Terminalia
avicennioides, Bridella ferruginea, Ageratum conyzoides Oci-
mum gratissimum, Acalypha wilkesiana and Phylantus discoi-
deus for the cure of patients with S. aureus-associated
diseases such as, eczema, carbuncles and osteomyelitis is
on the increase.
Terminalia. avicennioides (Combretaceae) is a yellowish
brown, hard and durable wood. The roots which are used
as chewing sticks have been claimed to cure dental caries
and skin infections[14]. Previous studies, showed that the
bark extract of T. avicennioides exhibited both vibrocidal
and typhoidal activities[15,16]. A. conyzoides (Compositae)
is an annual herb abundant in preclusive forests and farm-
land in southern part of Nigeria. Previous study showed
that methanolic leaf extracts corrected fibrinogaemia in
poultry chicks. Also both methanol and water extracts of
the leaves exhibited anti-bacterial effect[17]. B. ferruginea
(Euphorbiaceae) is used for treatment of insomnia. The
bark in combination with other herbs is used to cure pile
in western part of Nigeria[18].
Like other Ocimum spp, Ocimum gratissimum (Lamiaceae)
traditionally called "Efirin-Aja" has been reported to have
medicinal properties. The leaf extracts are popularly used
for the treatment of diarrhea while the cold leaf infusions
are used for the relief of stomach upset and haemorrhoids.
The thymol-riched leaf has been reported to have antimi-
crobial properties[19]. Acalypha wilkesiana (Euphorbiaceae)
is popularly used for the treatment of malaria, dermato-
logical and gastrointestinal disorders[20]. The bark extract
of P. discoideus (Euphorbiaceae) is used locally to cure
stomachache and lumbago.
The reputed efficacies of these plants have been experi-
enced and passed on from one generation to the other.
Apparently, lack of scientific proof of efficacies claimed by
traditional medical practitioners in Nigeria called for this
study. The present study investigates effects of these
medicinal plants against Methicillin Resistant S. aureus.
Methods
Fresh plant materials were collected from users of these
plants in Imota, Ikorodu, Ojo and Kosofe in Lagos State,
Nigeria. Their botanical identities were determined and
authenticated by Mr. O. K. Oluwa in Botany department,
Lagos State University, Ojo, Lagos. Samples were depos-
ited in the department herbarium.
Extraction
The extraction method used in this study was a modifica-
tion of Akinside & Olukoya,[15] and Akinyemi et al.[16].
In line with the traditional methods of preparation, shred-
ded plant materials were put in sterile bottles containing
either distilled water or 40% ethanol.
Water extract
Leaves of B. ferruginea (P) and A. conyzoides, (Q), and stem
barks of T. avicennioides (R) P. discoideus (S) O. gratissimum
(T) and A. wilkesiana (U) were oven-dried at temperature
of 60°C for 6 days. They were subsequently grounded into
fine powder in 25 ml of sterile distilled water, maintained
at 60°C for 3 hr. The resulting suspensions were filtered
and evaporated to dryness at 60°C in vacuo to produce
0.031, 0.041, 0.038, 0.042, 0.044 and 0.035 g of P, Q, R,
S, T, and U respectively. They were further labeled as aque-
ous extracts and designated as PW, QW, RW SW, TW, and
UW respectively.
Ethanol extract
Six grams of each of the powdered plant materials were
put in a soxhlet extractor containing 25 ml of 40% etha-
nol. The resulting extracts were subsequently weighed toPage 2 of 7
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P, Q, R, S, T, and U respectively. They were labeled as eth-
anol extracts and designed PE, QE, RE, SE, TW and UW
respectively.
Bacterial culture
The MRSA strains used in this study were clinical isolates
from urethral swab, seminal fluid, urine, high virginal
swab, blood, skin swab and sputum of patients presenting
with symptoms of S. aureus-associated diseases. The iso-
lates were identified by standard method[21]. Methicillin
resistant S. aureus was determined by the reference broth
microdilution methods using the established NCCLS[22]
break points. The standard strain used was S. aureus
NCIB 8588. The organisms were maintained on agar slope
at 4°C and sub-cultured for 24 hr before use.
Bacterial susceptibility testing
A standardized inoculum (1–2 × 107 cfu/ml 0.5 McFar-
land standards) was introduced onto the surface of sterile
agar plates, and a sterile glass spreader was used for even
distribution of the inoculum. A sterile paper disc previ-
ously soaked in a known concentration of extract (20
mcg/ml per disc) was carefully placed at the centre of the
labeled seeded plate. The same procedure was used for all
the MRSA strains used. The plates were incubated aerobi-
cally at 37°C and examined for zones of inhibition after
24 hr. The inhibition zones were measured with a ruler
and compared with the control disc23 (disc containing
only physiological saline).
Determination of minimum inhibitory concentration 
(MIC) and minimum bactericidal concentration (MBC)
MIC of the extracts was determined by dilution of P, Q, R,
S, T &.U to various concentrations of 0.0–32, 0.0–91, 0.0–
38, 0.0–42, 0.0–44 and 0.0–35 mcg/ml respectively.
Equal volume of each extract and nutrient broth were
mixed in a test tube. Specifically 0.1 ml of standardized
inoculum (1–2 × 107 cfu/ml) was added to each tube. The
tubes were incubated aerobically at 37°C for 18–24 hr.
Two control tubes were maintained for each test batch.
These included antibiotic control (tube containing extract
and the growth medium without inoculum) and organ-
ism control (the tube containing the growth medium,
physiological saline and the inoculum). The lowest con-
centration (highest dilution) of the extract that produced
no visible bacterial growth (no turbidity) when compared
with the control tubes was regarded as MIC. However, the
MBC was determined by subculturing the test dilution on
to a fresh drug-free solid medium and incubated further
for 18–24 hr. The highest dilution that yielded no single
bacterial colony on a solid medium was taken as MBC.
Phytochemical screening methods
All plant parts were extracted on the day of collection. The
screening procedures were adapted from Wall et al.,[24]
and Sofowora[25]. An extraction of each plant part was
prepared by macerating a known weight of the fresh plant
material in a blender with redistilled methylated spirit.
Each extract was suction-filtered and the process repeated
until all soluble compounds had been extracted, as judged
by loss of colour of the filtrate. Extract from each plant
part was evaporated to dryness in vacuo at about 45°C
and further dried to a constant weight at the same temper-
ature in a hot-air oven. A portion of the residue was used
to test for plant constituents.
The test for tannins was carried out by subjecting 3 g of
each plant extract in 6 ml of distilled water, filtered and
ferric chloride reagents added to the filtrate. For cardiac
glycosides, legal test and the Killer-Kiliani test[26] were
adopted (0.5 g of extract was added to 2 ml acetic anhy-
drate plus H2SO4). The test for alkaloids was carried out
by subjecting 0.5 g aqueous extract in 5 ml 1% HCl,
boiled, filtered and Mayer's reagent added [26,27]. Cya-
nogenic glycosides were identified by subjecting 0.5 g
extract in 10 ml sterile water, and were filtered. Sodium
picrate paper was added to the filtrate and heated to boil.
The extract was also tested for carbohydrates using resor-
cinol solution[24]. The extract was subjected to frothing
test for the identification of saponin. Haemolysis test was
further performed on the froted extracts in water to
remove false positive results[25]. Fehling's solution was
added to the extract and heated to detect reducing sugar.
The extract was also tested for free glycoside bound
anthraquinones[24,25]. Five grams of extract was added
to 10 ml benzene, filtered and ammonia solution added.
The presence of flavonoids was determined using 1% alu-
minum chloride solution in methanol concentrated HCl,
magnesium turnins, and potassium hydroxide
solution[28].
Results
The profile of six medicinal plants used in this study is
shown in Table 1. The results of antibacterial activity of
the crude extracts of these plants revealed that only four of
the six plants: T. avicennioides, P. discoideus, O. gratissimum
and A. wilkesiana showed good antibacterial activity
against MRSA used.
Both water and ethanol extracts of these plants were effec-
tive on MRSA strains. On the other hand, the crude
extracts (water & ethanol) of B. ferruginea and A. conyzoides
were weakly effective against the cocci as judged by the
zones of inhibition (Table 2). The MIC and MBC values
obtained for the extracts against the MRSA varied from
one plant extract to the other. For instance, the MIC values
of 20.8 and 18.2 mcg/ml were obtained for water andPage 3 of 7
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corresponding MBC values are 33.0 and 30.4 mcg/ml. The
MIC and MBC values of 43.0 and 63.2 mcg/ml were
recorded for ethanol extract and 71.0 and 84.2 mcg/ml for
water extract of A. conyzoides respectively. Also, MIC &
MBC values of 55.4 & 63.6 mcg/ml and 30.6 & 55.0 mcg/
ml were obtained for water and ethanol extracts of B. fer-
ruginea respectively. These plant extracts were bacterio-
static at lower concentrations and bactericidal at higher
concentrations as revealed by MIC and MBC values (Table
3).
The result of photochemical screening showed that all the
six tested plants exhibited positive reactions to alkaloids,
tannins and saponins. However, anthraquinone was only
found in the four active plants in this study. None con-
Table 1: Profile of the six medicinal plants used
Botanical Name Family Local name Plant part used Voucher Number
Bridella ferruginea Engl. Euphorbiaceae Ira Odun Leaf LSH
Ageratum conyzoides Linn. Compositae Imi-Isu Leaf LSH
Terminalia avicennioides Guill & Perr. Combretaceae Idi Bark LSH
Phylantus discoideus muel. Muel-Arg. Euphorbiaceae Asin Bark LSH
Ocimum gratissimum Linn. Lamiaceae Efirin Aja Leaf LSH
Acalypha wilkesiana Muell-Arg. Euphorbiaceae Eweeala Leaf LSH
Table 2: Antibacterial activity of the crude plant extracts on MRSA
Plants used MRSA (n = 23) *S aureus
Water extract Ethanol extract Water extract Ethanol extract
B. ferruginea 2.6 4.7 2.4 4.6
A. conyzoides 2.0 3.3 2.1 3.4
T. avicennioides 12.2 17.6 12.0 18.0
P. discoideus 11.5 16.0 11.2 16.1
O. gratissimum 10.2 10.3 9.0 9.5
A. wilkesiana 8.3 9.5 8.2 9.2
Methicillin - - - -
Oxacillin - - - -
Activity key: Figures indicate average zone of inhibition (in mm), (-) = no inhibition, *S. aureus (NCIB 8588) = standard strain used. Methicillin & 
Oxacillin = (commercial antibiotics), n = number of MRSA tested.
Table 3: Minimum inhibitory and bactericidal concentrations of plant extracts on MRSA.
Plant tested Water extract Ethanol extract
MIC MBC MIC MBC
B. ferruginea 55.4 63.6 30.6 55.0
A. conyzoides 71.0 84.2 43.0 63.2
T. avicennioides 20.8 33.0 18.2 30.4
P. discoideus 23.0 34.2 20.5 33.0
O. gratissimum 25.0 37.0 22.3 35.2
A. wilkesiana 24.5 37.0 24. 37.0
Key: mcg = microgramPage 4 of 7
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Reducing and non-reducing carbohydrates were found in
P discoideus, O. gratissimum and T. avicennioides (Table 4).
Discussion
Medicinal plants constitute an effective source of both tra-
ditional and modern medicines, herbal medicine has
been shown to have genuine utility and about 80% of
rural population depends on it as primary health care.
Over the years, the World Health Organization advocated
that countries should interact with traditional medicine
with a view to identifying and exploiting aspects that pro-
vide safe and effective remedies for ailments of both
microbial and non-microbial origins[29].
The results of the study indicated that four out of six
medicinal plants commonly used by traditional medical
practitioners to cure skin and upper respiratory tract infec-
tions such as pneumonia, carbuncle, purple, impetigo and
tonsillitis were active against hospital strains of MRSA.
The crude extracts of B. ferruginea and A. conyzoides were
weakly active against MRSA strains with ethanol extract of
both plants exerting stronger antibacterial activity than
water extracts. Previous studies by Ogbeche et al.[17] and
Oluyemi[18] indicated that the crude extracts of these
plants were effective against S. aureus. The present study
was slightly conformed to their findings but the only area
of concern is that while their studies only dealt with the
effect of crude extracts on S. aureus, our study focused on
the effect of crude extract on the MRSA, and determina-
tion of both MIC & MBC values of the extracts.
For example, the MIC values of 30.6 and 43.0 mcg/ml
obtained for ethanol extracts of B. ferruginea and A.
conyzoides in this study were lowered than their corre-
sponding water extracts of 55.4 and 71.0 mcg/ml. Simi-
larly, MBC values of 63.6 and 84.2 mcg/ml were recorded
for ethanol extract of B. ferruginea and A. conyzoides respec-
tively (Table 3). These values were too high to be consid-
ered active against the pathogen. It is worthy of note that
traditional medical practitioners used these plant extracts
solely without combining with other plant extracts for the
treatment of MRSA-associated skin and respiratory dis-
eases. This finding may disagree with the traditional ther-
apeutic indications claimed on these plants we therefore
suggest the immediate stoppage of their traditional use
against MRSA-associated diseases in Lagos, Nigeria. How-
ever, the in-vitro inactivity of these plants on MRSA may
not necessarily translate to their in-vivo inactivity but the
extracts may probably be playing immuno-modulatory
roles in the body system. Bever[30] had documented
immunodulation of chemical compounds from medici-
nal plants many of which have been proved to be inactive
or weakly active in-vitro against pathogens. In this study,
we are unable to determine immuno-modulating action
of these plants due to lack of facilities.
Our investigation further showed that both water and eth-
anol extracts of T. avicennioides, P. discoideus, O.
gratissimum and A. wilkessiana were active against S. aureus
and MRSA. The MIC value of the four active plant extracts
obtained in this study were lower than the MBC values
suggesting that the plant extracts were bacteriostatic at
lower concentration and bactericidal at higher concentra-
tion. The ethanol extract of the four plants exerted greater
Table 4: Phytochemical analysis of six crude plant extracts
Screened plants.












Alkaloids ++ ++ ++ +++ ++ ++
Tannins ++ ++ +++ +++ +++ ++
Saponins ++ ++ +++ +++ ++ ++
Anthraquinone + + +++ +
Cardiac glycosides - - - - -
Cyanogenic glycosides - - - - - -
Flavonoides + + + + + +
Reducing and non-reducing 
carbohydrates
- - +++ +++ +++ -
Parenthesis = Plant part
+++ = Appreciable amount
++ = Moderate amount
+ = Trace amount
- = Completely absencePage 5 of 7
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(Tables 2 and 3) at the same concentrations. These obser-
vations may be attributed to two reasons; firstly, the
nature of biological active components (saponins, tan-
nins, alkaloids and anthraquinone) which could be
enhanced in the presence of ethanol. It has been docu-
mented that tannins, saponins and alkaloids are plants
metabolites well known for antimicrobial activity[31].
Secondly, the stronger extraction capacity of ethanol
could have produced greater number of active constitu-
ents responsible for antibacterial activity.
Traditionally, leaves of O. gratissimum and A. wilkesiana
and barks of T. avicenniodes and P. discoideus are soaked in
ethanol or water (in case of patients forbidding alcoholic
intake due to religious belief) for days, large quantities of
these extracts, which lack specific concentration are usu-
ally administered to patients. Our results therefore tend to
support the traditional claim that these four medicinal
plants are preferably extracted in ethanol. Strong vibrio-
cidal activity of water and ethanol extracts of T. avicennio-
ides and typhoidal activity of aqueous extracts of O.
gratissimum had been reported in Lagos, Nigeria [15,16].
The result of phytochemical screening of six plants indi-
cated the presence of tannins, alkaloids and saponins.
Interestingly, only the four plant extracts that were active
against MRSA in this study contained at least trace amount
of anthraquinone (Table 4). It is therefore most probable
that the presence of anthraquinone contributed to anti-
MRSA activity observed. We were unable to carry out bio-
autography of the extracts due to lack of facilities.
Conclusion
Our results therefore offer a scientific basis for the tradi-
tional use of both water and ethanol extracts of A. wilkesi-
ana, O. gratissimum, T. avicennioides and P. discoideus
separately against MRSA-associated skin and respiratory
diseases. But in vivo studies on these medicinal plants are
necessary and should seek to determine toxicity of the
active constituents, their side effects, serum-attainable lev-
els, pharmacokinetic properties and diffusion in different
body sites. The antimicrobial activities could be enhanced
if the active components are purified and adequate dosage
determined for proper administration. This may go a long
way in curbing administration of inappropriate concen-
tration; a common practice among many traditional med-
ical practitioners in Nigeria. This study represents the first
preliminary report on anti-methicillin resistant Staphyloco-
ccus aureus activity of the crude extracts of these medicinal
plants in Lagos, Nigeria.
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